We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAGE
12376
CALL
Niagen Bioscience
NAGE
$254M
$63K ﹤0.01%
16,800
-165,500
-91% -$894K
ONCR
12377
CALL
DELISTED
Oncorus, Inc.
ONCR
$63K ﹤0.01%
+11,900
New +$92.1K
DYAI icon
12378
Dyadic International
DYAI
$25.6M
$62K ﹤0.01%
13,608
-9,831
-42% -$41.9K
SNCR
12379
CALL
DELISTED
Synchronoss Technologies
SNCR
$62K ﹤0.01%
2,833
-5,634
-67% -$128K
AAC.WS
12380
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$62K ﹤0.01%
69,161
+119
+0.2% +$125
GNCA
12381
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$62K ﹤0.01%
53,100
+33,400
+170% +$49.8K
AEMD icon
12382
Aethlon Medical
AEMD
$1.54M
$61K ﹤0.01%
+8
New +$91.1K
DHC
12383
PUT
Diversified Healthcare Trust
DHC
$1.9B
$61K ﹤0.01%
+19,700
New +$63.7K
KRRO icon
12384
PUT
Korro Bio
KRRO
$195M
$61K ﹤0.01%
238
-1,046
-81% -$318K
IMDX
12385
PUT
Insight Molecular Diagnostics
IMDX
$140M
$61K ﹤0.01%
1,405
+160
+13% +$9.2K
PLX icon
12386
PUT
Protalix BioTherapeutics
PLX
$210M
$61K ﹤0.01%
73,100
-127,700
-64% -$134K
MTNB icon
12387
Matinas BioPharma
MTNB
$2.94M
$60K ﹤0.01%
+1,191
New +$63.7K
KLDO
12388
PUT
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$60K ﹤0.01%
25,000
+14,400
+136% +$58.6K
LAIX
12389
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
$60K ﹤0.01%
+7,677
New +$88.2K
BSBR icon
12390
PUT
Santander
BSBR
$42.9B
$59K ﹤0.01%
+11,000
New +$66.2K
CIFRW
12391
DELISTED
Cipher Mining Warrant
CIFRW
$59K ﹤0.01%
50,000
HELP
12392
Cybin Inc
HELP
$967M
$59K ﹤0.01%
1,288
+992
+335% +$62.8K
DRRX
12393
DELISTED
DURECT Corp
DRRX
$59K ﹤0.01%
6,031
+1,890
+46% +$20.9K
FTFT icon
12394
PUT
Future FinTech Group
FTFT
$18.8M
$59K ﹤0.01%
56
-113
-67% -$157K
FTK icon
12395
PUT
Flotek Industries
FTK
$884M
$59K ﹤0.01%
8,750
+6,117
+232% +$34.8K
GLBS icon
12396
PUT
Globus Maritime Ltd
GLBS
$77.9M
$59K ﹤0.01%
28,100
-18,100
-39% -$48.3K
LQDA icon
12397
PUT
Liquidia Corp
LQDA
$6.26B
$59K ﹤0.01%
12,100
-12,600
-51% -$50.2K
NNBR icon
12398
NN Inc
NNBR
$295M
$59K ﹤0.01%
+14,427
New +$70.7K
NRDY icon
12399
PUT
Nerdy
NRDY
$88M
$59K ﹤0.01%
880
-4,733
-84% -$507K
SVM
12400
CALL
Silvercorp Metals
SVM
$2.98B
$59K ﹤0.01%
15,600
-30,800
-66% -$125K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.